Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4H4B0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.251 |
CLV_PCSK_KEX2_1 | 276 | 278 | PF00082 | 0.581 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.384 |
CLV_PCSK_PC1ET2_1 | 276 | 278 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.267 |
CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.306 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.447 |
DEG_SPOP_SBC_1 | 108 | 112 | PF00917 | 0.173 |
DEG_SPOP_SBC_1 | 36 | 40 | PF00917 | 0.594 |
DOC_CYCLIN_yCln2_LP_2 | 129 | 135 | PF00134 | 0.385 |
DOC_MAPK_MEF2A_6 | 197 | 206 | PF00069 | 0.295 |
DOC_MAPK_MEF2A_6 | 257 | 266 | PF00069 | 0.272 |
DOC_PP2B_LxvP_1 | 129 | 132 | PF13499 | 0.385 |
DOC_PP2B_LxvP_1 | 251 | 254 | PF13499 | 0.413 |
DOC_USP7_MATH_1 | 180 | 184 | PF00917 | 0.278 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.242 |
DOC_USP7_MATH_1 | 202 | 206 | PF00917 | 0.381 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.578 |
DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.298 |
DOC_WW_Pin1_4 | 278 | 283 | PF00397 | 0.418 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.462 |
LIG_14-3-3_CanoR_1 | 12 | 20 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 24 | 30 | PF00244 | 0.330 |
LIG_14-3-3_CanoR_1 | 257 | 261 | PF00244 | 0.302 |
LIG_14-3-3_CanoR_1 | 283 | 292 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 31 | 37 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 66 | 74 | PF00244 | 0.270 |
LIG_14-3-3_CanoR_1 | 86 | 96 | PF00244 | 0.357 |
LIG_BRCT_BRCA1_1 | 15 | 19 | PF00533 | 0.397 |
LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.404 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.298 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.304 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.254 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.269 |
LIG_FHA_2 | 268 | 274 | PF00498 | 0.407 |
LIG_LIR_Apic_2 | 156 | 162 | PF02991 | 0.353 |
LIG_LIR_Apic_2 | 256 | 261 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 223 | 232 | PF02991 | 0.272 |
LIG_LIR_Gen_1 | 289 | 295 | PF02991 | 0.512 |
LIG_LIR_Nem_3 | 157 | 163 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.275 |
LIG_LIR_Nem_3 | 289 | 295 | PF02991 | 0.512 |
LIG_PTB_Apo_2 | 168 | 175 | PF02174 | 0.333 |
LIG_PTB_Phospho_1 | 168 | 174 | PF10480 | 0.333 |
LIG_SH2_CRK | 160 | 164 | PF00017 | 0.277 |
LIG_SH2_CRK | 258 | 262 | PF00017 | 0.333 |
LIG_SH2_NCK_1 | 195 | 199 | PF00017 | 0.298 |
LIG_SH2_NCK_1 | 268 | 272 | PF00017 | 0.408 |
LIG_SH2_STAP1 | 195 | 199 | PF00017 | 0.393 |
LIG_SH2_STAP1 | 268 | 272 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.362 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.368 |
LIG_SH3_3 | 276 | 282 | PF00018 | 0.335 |
LIG_SUMO_SIM_par_1 | 259 | 265 | PF11976 | 0.272 |
LIG_SUMO_SIM_par_1 | 78 | 84 | PF11976 | 0.337 |
LIG_SxIP_EBH_1 | 216 | 226 | PF03271 | 0.333 |
MOD_CDK_SPK_2 | 278 | 283 | PF00069 | 0.339 |
MOD_CK1_1 | 189 | 195 | PF00069 | 0.288 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.442 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.609 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.528 |
MOD_CK2_1 | 267 | 273 | PF00069 | 0.396 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.607 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.286 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.311 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.423 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.498 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.285 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.214 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.594 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.626 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.298 |
MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.634 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.298 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.517 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.565 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.492 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.272 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.694 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.282 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.528 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.274 |
MOD_Plk_4 | 131 | 137 | PF00069 | 0.254 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.297 |
MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.298 |
MOD_ProDKin_1 | 278 | 284 | PF00069 | 0.414 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.461 |
TRG_ENDOCYTIC_2 | 160 | 163 | PF00928 | 0.303 |
TRG_ENDOCYTIC_2 | 173 | 176 | PF00928 | 0.275 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.344 |
TRG_ER_diArg_1 | 85 | 87 | PF00400 | 0.251 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5M3 | Leptomonas seymouri | 64% | 93% |
A0A1X0NKR5 | Trypanosomatidae | 54% | 94% |
A0A3R7M8G7 | Trypanosoma rangeli | 59% | 96% |
A0A3S5H5J0 | Leishmania donovani | 82% | 91% |
A4HSI8 | Leishmania infantum | 82% | 91% |
C9ZUB5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 92% |
E9AKH2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 94% |
P81102 | Bacillus subtilis (strain 168) | 25% | 100% |
Q4QJD6 | Leishmania major | 80% | 100% |
Q60049 | Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) | 30% | 100% |
V5BAS5 | Trypanosoma cruzi | 57% | 93% |